hyper tonic saline in the treatment of intracranial hypertension
TRANSCRIPT
-
8/6/2019 Hyper Tonic Saline in the Treatment of Intracranial Hypertension
1/19
Hypertonic Saline in the Treatment of Intracranial Hypertension
Laura J Griffin MSN, APRN, CCRN, ACNP-BC
Doctor of Nursing Practice Candidate
The University of Texas Health Science Center at Houston School of Nursing
Citation: L. Griffin : Hypertonic Saline in the Treatment of Intracranial Hypertension.
The Internet Journal of Advanced Nursing Practice. 2010 Volume 11 Number 1
Keywords: intracranial hypertension | brain edema | hypertonic saline | osmotic therapy |
brain injury | intracranial pressure
Table of Contents
Background
Intracranial Hypertension
Hypersomolar Therapy Principles
Hypertonic Saline
Findings
Traumatic Brain Injury
Mixed Neurological Insults
Subarachnoid Hemorrhage
Stroke
Patient Outcomes
Limitations
Potential Adverse Effects
Research Implications Conclusions
Correspondence to
Abstract
http://www.ispub.com/journal/the_internet_journal_of_advanced_nursing_practice/volume_11_number_1_11/article/hypertonic-saline-in-the-treatment-of-intracranial-hypertension.html#h1-0http://www.ispub.com/journal/the_internet_journal_of_advanced_nursing_practice/volume_11_number_1_11/article/hypertonic-saline-in-the-treatment-of-intracranial-hypertension.html#h2-0http://www.ispub.com/journal/the_internet_journal_of_advanced_nursing_practice/volume_11_number_1_11/article/hypertonic-saline-in-the-treatment-of-intracranial-hypertension.html#h1-1http://www.ispub.com/journal/the_internet_journal_of_advanced_nursing_practice/volume_11_number_1_11/article/hypertonic-saline-in-the-treatment-of-intracranial-hypertension.html#h1-2http://www.ispub.com/journal/the_internet_journal_of_advanced_nursing_practice/volume_11_number_1_11/article/hypertonic-saline-in-the-treatment-of-intracranial-hypertension.html#h1-3http://www.ispub.com/journal/the_internet_journal_of_advanced_nursing_practice/volume_11_number_1_11/article/hypertonic-saline-in-the-treatment-of-intracranial-hypertension.html#h2-1http://www.ispub.com/journal/the_internet_journal_of_advanced_nursing_practice/volume_11_number_1_11/article/hypertonic-saline-in-the-treatment-of-intracranial-hypertension.html#h2-2http://www.ispub.com/journal/the_internet_journal_of_advanced_nursing_practice/volume_11_number_1_11/article/hypertonic-saline-in-the-treatment-of-intracranial-hypertension.html#h2-3http://www.ispub.com/journal/the_internet_journal_of_advanced_nursing_practice/volume_11_number_1_11/article/hypertonic-saline-in-the-treatment-of-intracranial-hypertension.html#h2-4http://www.ispub.com/journal/the_internet_journal_of_advanced_nursing_practice/volume_11_number_1_11/article/hypertonic-saline-in-the-treatment-of-intracranial-hypertension.html#h2-5http://www.ispub.com/journal/the_internet_journal_of_advanced_nursing_practice/volume_11_number_1_11/article/hypertonic-saline-in-the-treatment-of-intracranial-hypertension.html#h2-6http://www.ispub.com/journal/the_internet_journal_of_advanced_nursing_practice/volume_11_number_1_11/article/hypertonic-saline-in-the-treatment-of-intracranial-hypertension.html#h1-4http://www.ispub.com/journal/the_internet_journal_of_advanced_nursing_practice/volume_11_number_1_11/article/hypertonic-saline-in-the-treatment-of-intracranial-hypertension.html#h1-5http://www.ispub.com/journal/the_internet_journal_of_advanced_nursing_practice/volume_11_number_1_11/article/hypertonic-saline-in-the-treatment-of-intracranial-hypertension.html#h1-6http://www.ispub.com/journal/the_internet_journal_of_advanced_nursing_practice/volume_11_number_1_11/article/hypertonic-saline-in-the-treatment-of-intracranial-hypertension.html#h2-7http://www.ispub.com/journal/the_internet_journal_of_advanced_nursing_practice/volume_11_number_1_11/article/hypertonic-saline-in-the-treatment-of-intracranial-hypertension.htmlhttp://www.ispub.com/journal/the_internet_journal_of_advanced_nursing_practice/volume_11_number_1_11/article/hypertonic-saline-in-the-treatment-of-intracranial-hypertension.html#h1-0http://www.ispub.com/journal/the_internet_journal_of_advanced_nursing_practice/volume_11_number_1_11/article/hypertonic-saline-in-the-treatment-of-intracranial-hypertension.html#h2-0http://www.ispub.com/journal/the_internet_journal_of_advanced_nursing_practice/volume_11_number_1_11/article/hypertonic-saline-in-the-treatment-of-intracranial-hypertension.html#h1-1http://www.ispub.com/journal/the_internet_journal_of_advanced_nursing_practice/volume_11_number_1_11/article/hypertonic-saline-in-the-treatment-of-intracranial-hypertension.html#h1-2http://www.ispub.com/journal/the_internet_journal_of_advanced_nursing_practice/volume_11_number_1_11/article/hypertonic-saline-in-the-treatment-of-intracranial-hypertension.html#h1-3http://www.ispub.com/journal/the_internet_journal_of_advanced_nursing_practice/volume_11_number_1_11/article/hypertonic-saline-in-the-treatment-of-intracranial-hypertension.html#h2-1http://www.ispub.com/journal/the_internet_journal_of_advanced_nursing_practice/volume_11_number_1_11/article/hypertonic-saline-in-the-treatment-of-intracranial-hypertension.html#h2-2http://www.ispub.com/journal/the_internet_journal_of_advanced_nursing_practice/volume_11_number_1_11/article/hypertonic-saline-in-the-treatment-of-intracranial-hypertension.html#h2-3http://www.ispub.com/journal/the_internet_journal_of_advanced_nursing_practice/volume_11_number_1_11/article/hypertonic-saline-in-the-treatment-of-intracranial-hypertension.html#h2-4http://www.ispub.com/journal/the_internet_journal_of_advanced_nursing_practice/volume_11_number_1_11/article/hypertonic-saline-in-the-treatment-of-intracranial-hypertension.html#h2-5http://www.ispub.com/journal/the_internet_journal_of_advanced_nursing_practice/volume_11_number_1_11/article/hypertonic-saline-in-the-treatment-of-intracranial-hypertension.html#h2-6http://www.ispub.com/journal/the_internet_journal_of_advanced_nursing_practice/volume_11_number_1_11/article/hypertonic-saline-in-the-treatment-of-intracranial-hypertension.html#h1-4http://www.ispub.com/journal/the_internet_journal_of_advanced_nursing_practice/volume_11_number_1_11/article/hypertonic-saline-in-the-treatment-of-intracranial-hypertension.html#h1-5http://www.ispub.com/journal/the_internet_journal_of_advanced_nursing_practice/volume_11_number_1_11/article/hypertonic-saline-in-the-treatment-of-intracranial-hypertension.html#h1-6http://www.ispub.com/journal/the_internet_journal_of_advanced_nursing_practice/volume_11_number_1_11/article/hypertonic-saline-in-the-treatment-of-intracranial-hypertension.html#h2-7 -
8/6/2019 Hyper Tonic Saline in the Treatment of Intracranial Hypertension
2/19
Background:Intracranial hypertension is a life threatening complication affecting the
neurological patient. Limited options for treatment can be challenging for healthcare
providers. Current research seems to support the effectiveness of hypertonic saline in
reducing intracranial pressure. Objectives:This article will review the literature to
ascertain the safety and efficacy of hypertonic saline in the treatment of intracranial
hypertension.Method: In order to assess the effect of hypertonic saline administered for
the treatment of intracranial hypertension on intracranial pressure, a search of PubMed,
Ebsco, Scopus, and the Cochrane Library was performed. Search criteria used for this
review included adult human studies using brain edema, neurological injury, intracranial
hypertension, brain injury, stroke, subarachnoid hemorrhage, and hypertonic saline as
search terms yielded 29 studies which were reviewed. Case reports, letters to the editor,
languages other than English, and those which included pediatric participants were
excluded. Also excluded were studies that involved use of hypertonic saline
intraoperatively, studies that focused on the initial resuscitation of traumatic brain injury,
those used for purely elective neurosurgical resuscitation of traumatic brain injury, and
those used for purely elective neurosurgical patients. Elective neurosurgical patients were
excluded since intracranial hypertension is frequently reversed with surgical evacuation
of space occupying lesion and not medical therapy. Of the 29 studies that were obtained,
5 were excluded. Two were case studies. One dealt with the intra-operative use of
hypertonic saline, and two other studies has foci related to variables other than effect on
intracranial hypertension.Results: Whether used as an initial treatment for elevated
intracranial pressure or as a rescue therapy for refractory intracranial hypertension,
hypertonic saline appears to offer an additional means for lowering intracranial pressure
and may provide a bridge to emergent surgical decompression.
Background
Intracranial hypertension (IH) resulting from increased intracranial pressure is a common
complication of neurological injuries. Research has shown that IH is associated with poor
patient outcomes.1 In an effort to improve morbidity and mortality in these patients,
neurologically based research has focused on strategies to reduce IH. Osmotic therapy
has long been recognized as a safe and effective treatment for IH.2 The most researched
-
8/6/2019 Hyper Tonic Saline in the Treatment of Intracranial Hypertension
3/19
and commonly used osmotic agent, mannitol, has been associated with untoward side
effects. In an effort to find an effective osmotic agent with a safe side effect profile, other
osmotic agents have gained some popularity. This article will review studies performed
using HS as an osmotic agent for the reduction of intracranial pressure in patients with
neurological injury.
Intracranial Hypertension
The cranial vault, or skull, of an average adult has an approximate volume of 1700
milliliters. Eighty-percent of this volume is comprised of brain tissue and the other
twenty percent is comprised of blood and cerebral spinal fluid.3 In a healthy individual,
compensatory mechanisms keep these contents at a constant volume. When a person
suffers from a neurological insult, normal compensatory mechanisms may fail and the
delicate balance is disrupted. The Monro-Kellie doctrine states that the total contents of
the cranial vault must remain at a constant volume in order to maintain equilibrium. If
any one of the contents increases in volume without a corresponding compensatory
decrease in another, the pressure in the cranial vault will increase resulting in intracranial
hypertension. A normal intracranial pressure (ICP) is considered to be 5-10mmHg.1
Intracranial hypertension is defined as an intracranial pressure above normal limits.
Research has shown that values above 20 mmHg are associated with increased morbidity
and mortality.2 Therefore, most institutions including the Brain Trauma Foundation
suggest initiating osmotic treatment for values above 20 mmHg lasting for more than five
minutes.2 The most common cause of IH in patients with neurological insults is related to
increased brain volume either from a space occupying lesion or cerebral edema. Space
occupying lesions, such as tumors, can be treated with surgical evacuation. In contrast,
medical management in the form of osmotic therapy is the cornerstone of treatment for
cerebral edema.
Hypersomolar Therapy Principles
-
8/6/2019 Hyper Tonic Saline in the Treatment of Intracranial Hypertension
4/19
A traditionally held belief is that hyperosmolar therapy effectiveness is a result of brain
shrinkage caused from the shifting of water out of the brain. Mannitol has been accepted
as treatment for IH, and is considered a safe and effective osmotic diuretic. Considered
the drug of choice for IH in Guidelines for the Management of Severe Brain Injury,
mannitol is not without its drawbacks.2 Mannitol, an osmotic diuretic, has been associated
with volume depletion and hypotension leading to secondary injury to the brain. Injury to
the blood brain barrier (BBB), often found in neurological injuries, can be a confounding
factor in the management of IH. One concern is that solutes may escape from the vascular
system to the brain tissue. In the presence of an injured BBB, mannitol may escape the
intravascular space and accumulate in already edematous tissue, which may lead to an
increase in cerebral edema and intracranial hypertension often referred to as rebound
phenomenon.
In an attempt to find the optimal hyperosmolar agent, the use of other solutions has
been explored. An optimal agent should be nontoxic, simple to administer with minimal
side effects, have a strong osmotic gradient, and would remain in the intravascular space
(reflection coefficient). Reflection coefficient is the measurement of how well a solute
crosses a membrane. In regards to treatment of IH, a reflection coefficient of 1 is given to
a solute that stays in the intravascular space and is impermeable to an intact BBB (See
Table 1).
Table 1. Reflection Coefficients
Research has found other agents such as glycerol and urea, with their low reflectioncoefficients, to be fairly ineffective osmotic agents in the treatment of IH.4 Hypertonic
saline with its low cost, ease of administration, and titratable osmotic gradient (by
adjusting its concentration), and its reflection coefficient of 1 has been recognized as an
effective osmotic agent.
-
8/6/2019 Hyper Tonic Saline in the Treatment of Intracranial Hypertension
5/19
Hypertonic Saline
The use of hypertonic saline in the treatment of cerebral edema was first proposed in1919 by Weed and McKibben.5 Nearly forgotten, more than sixty years later HS
reemerged as resuscitation agent for patients in shock. Incidentally found through the
resuscitations of patients with multi-organ trauma, use of HS in patients with
neurotrauma alone became a focus of research.6,7 Finding from this early research, in
multi-organ trauma, including brain injury, promoted its use in the treatment of
intracranial hypertension and herniation syndromes as well.
The proposed mechanism of action of HS is similar to that of mannitol. Through osmosis
HS draws water out of the intracellular space, the edematous brain, and back into the
intravascular space. In addition, HS has been shown to be effective in resuscitation of
patients in shock by the same mechanism. Unlike mannitol which promotes diuresis, HS
increases blood volume, decreases viscosity, and increases preload. All of these
characteristics lead to an increase in blood pressure, cardiac output, and cerebral
perfusion pressure (CPP), thereby improving perfusion to the brain and decreasing
secondary injury. Used as a resuscitation agent, HS also has potential to be used as acomponent of triple H therapy (hypervolemia, hemodilution, and hypertension) in the
treatment of patients with subarachnoid hemorrhage (SAH) who are at high risk of severe
vasospasm.
Findings
Traumatic Brain Injury
According the Centers for Disease Control, 1.4 million Americans suffer from traumatic
brain injury (TBI) annually. Of those, more than 200,000 are hospitalized and 50,000 die.
Costs related to TBI, direct and indirect, are figured to be approximately $60 billion. 8 In
an effort to improve morbidity and mortality rates in patients with TBI, research to
combat and treat IH has been on the forefront of neurological research. Most studies
-
8/6/2019 Hyper Tonic Saline in the Treatment of Intracranial Hypertension
6/19
involving TBI, share similar findings that indicate that HS is consistent with a decrease in
ICP and an increase in CPP (See Table 2). Maintaining a physiologic normal CPP is as
important as decreasing elevated ICP in preventing secondary injury. By increasing blood
volume and preload, HS helps to ensure adequate perfusion and oxygenation to at-risk
brain tissue.
Several studies compared mannitol boluses versus HS boluses.9,10 In one study, Vialet et
al. compared 20% mannitol with 7.5% sodium chloride (NaCl) bolus for the treatment of
ICP above 25mmHg. This study demonstrated that patients given mannitol have two
times more events of elevated ICP compared with HS. In addition, treatment failures
were 7 out of 10 for the mannitol group versus those treated with HS. Shackford et al.
took a unique approach and compared the use of slightly hypertonic solution of 1.6%NaCl with a slightly hypotonic solution of Lactated Ringers in the TBI population.11
Intracerebral pressures decreased in the HS group while the patients receiving Lactated
Ringers showed an upward trend in ICP. While most of the studies used bolus dosing, a
retrospective chart review by Quareshi et al. reviewed the use of HS as a continuous drip
with varying infusion rates with the goal of achieving a serum sodium value between
145-155 meq/dl. The investigators found that patients receiving continuous HS had poor
long-term outcomes as identified by the Glasgow Outcome Scale (GOS).12 The GOS
ranks patients on five levels based on functional recovery with 1 corresponding with
death and 5 corresponding with good recovery. Another unique study design examined
the effects of a bolus of 20% NaCl on not only the ICP but the measurable effect on brain
tissue using computed tomography.13 The results of this study revealed that HS may
lower ICP by decreasing the overall volume of the healthy brain tissue.
-
8/6/2019 Hyper Tonic Saline in the Treatment of Intracranial Hypertension
7/19
Table 2. Summary of Study Findings for Traumatic Brain Injury
Mixed Neurological Insults
Samples with mixed neurological injuries were examined in six studies (See Table 3).
Battison et al. examined the effect of equiosmolar does of mannitol versus HS. Findings
supported that both agents decreased ICP. Mannitol decreased ICP on average by 7.5
mmHg, whereas, HS decreased by 13.5 mmHg. The investigators also suggested that
patients who received HS appeared to have a longer duration of effect than those who
-
8/6/2019 Hyper Tonic Saline in the Treatment of Intracranial Hypertension
8/19
received mannitol.14 Francony et al. also compared equiosmolar doses of mannitol with
HS.15 Findings contrasted the research by Battison et al. showing that mannitol decreased
ICP better than HS, though none of the findings were statistically significant. Becoming
more popular as a rescue therapy for malignant IH (i.e., ICPs refractory to traditional
treatments), Koenig et al. reviewed the effect of 23.4 % bolus in patients with signs of
impending herniation syndromes. Concentrated HS was successful at reversing herniation
syndromes in 57 of the 76 events.16
Table 3. Summary of Study Findings for Mixed Neurological Injuries
Subarachnoid Hemorrhage
Only four studies were found that evaluated the use of HS in the SAH population (See
Table 4). Bentsen et al. evaluated the use of 7.5% HS combined with 6% hydroxyethyl
starch 2ml/kg bolus dose in two different studies.17 One study was performed in patients
with elevated ICP. 17 In the other study the same concentration and dose was given to
-
8/6/2019 Hyper Tonic Saline in the Treatment of Intracranial Hypertension
9/19
-
8/6/2019 Hyper Tonic Saline in the Treatment of Intracranial Hypertension
10/19
Table 4. Summary of Study Findings for Non-Traumatic Injuries
Limitations
All studies reviewed included small sample sizes and a few studies revealed some
selection bias. Often the use of HS was used as a rescue therapy or after the standard of
care had already failed to control intracranial pressure in the most critically ill patients.
Using HS earlier in the course of the patients treatment, instead of as a last resort may
provide better success. Another potential limitation to the studies as a group was that
saline concentrations varied greatly among investigators. Concentrations ranged from 2-
20% sodium chloride. Not all studies that compared mannitol with HS used equiosmolar
dosing (See Table 5).
-
8/6/2019 Hyper Tonic Saline in the Treatment of Intracranial Hypertension
11/19
Table 5. Comparing Osmolarity of IV Agents
Agents with a stronger osmotic action may affect the ICP values. Therefore, comparing
two agents of unequal osmolar activity may be considered unjust. Varying doses among
the study groups as a whole, as well as in individual studies, occurred throughout many
of the studies. This lack of consistency make findings difficult to generalized the entire
neurological population.
Potential Adverse Effects
Like other osmotic agents, side effects from the administration of HS are potential risks
that must be balanced with the potential benefits of its use. In the studies reviewed, no
significant complications were mentioned. Most studies listed exclusion criteria, to
minimize harm to patients who may be a highest risk for untoward effects. Patients
commonly excluded were those with heart failure, pulmonary edema, and kidney failure
who may be harmed from an increase in intravascular volume. In one study, lung water
was evaluated and unchanged over three hours post HS administration.17 In a
-
8/6/2019 Hyper Tonic Saline in the Treatment of Intracranial Hypertension
12/19
retrospective chart review, three patients that received HS developed pulmonary edema.
Of the three patients, one of them had underlying cardiomyopathy.12 In a study, that
specifically looked at complication in patients with neurological injury receiving
continuous infusion of HS, the incidence of renal failure was not found to correlate with
HS use.12 Hypernatremia, serum sodium levels greater than 155, did correlate with a
small yet statistically significant increase in BUN and creatinine levels.25
Central pontine myelinolysis (CPM), a demyelination of the pons is a concern during
administration of any concentrated sodium solution. First described in 1958, CPM is
associated with chronically hyponatremic patients who undergo rapid correction
hyponatremia with a concentrated saline solution. No evidence exists to support the fear
of CPM in patients with acute cerebral salt wasting, excessive renal secretion of sodiumin the face of neurological injury, or traumatic brain injury. Since CPM is an irreversible
and devastating condition, practitioners should continue to be cautious when
administrating HS until significant research proves whether or not this population is at
risk.
Electrolyte and acid base imbalances are frequent occurrence in the critical care patient
population. Several studies included potassium levels as dependent variables.23, 26 These
studies collectively revealed a mild decrease in potassium immediately following
administration with a rebound in potassium near baseline levels after a few hours. While
these studies suggest that hypokalemia may not be a concern for patients receiving HS
therapy, it may be wise to monitor potassium levels in patients who are receiving
frequent boluses of HS especially patients who are at risk of arrhythmias.
Hyperchloremic metabolic acidosis may result from continuous or frequent bolus doses
of HS. In the above studies, some institutions alternated sodium chloride concentrations
with sodium acetate concentrations to decrease its incidence.
In hemorrhagic neurological insults, an injured BBB may result in the translocation of
hyperosmolar solutions which have the potential to cause rebound IH. Animal studies
have found mannitol and HS to cross an injured BBB, but no studies have been done in
humans to evaluate post mortem effects of HS in the brain. Impaired platelet aggregation
-
8/6/2019 Hyper Tonic Saline in the Treatment of Intracranial Hypertension
13/19
and coagulopathy is a concern in hemorrhagic neurologic injuries. Animal studies have
suggested that hypertonic saline may be responsible for increased bleeding. In one human
study, clotting factors diminished when 10% of plasma was replaced with HS versus
normal saline.27 In another study, HS/dextran was similarly mixed with human plasma at
1:5 and 1:10 concentrations, with only minimal increase in PT.28 While none of the above
studies mentioned bleeding complications, no study has specifically looked at bleeding
complications in neurological patients receiving HS. Therefore, the clinician should
consider this possible complication in any patient receiving HS until research in this area
is completed.
Research Implications
The above studies provide a foundation for future research. In order to strengthen the
current foundation, future studies should strive for larger sample size. Noted in the above
studies were the varying concentrations and doses of HS. These variations make
assessment of the overall effectiveness of this solution difficult. Further research is
needed to strengthen the evidence for a standard therapy or to assess the effectiveness of
one concentration compared with another. Research is also needed in the SAH with
vasospasm population, who may benefit from the intravascular volume expansion that HS
offers. At this time, HS has not been shown to improve long-term outcomes, which may
be due to its use in refractory IH. Studies are needed in which HS is used as a treatment
of cerebral edema prior to other treatments. Finally, studies that focus on HS use in other
than severe traumatic brain injury should be considered for future research.
Conclusions
Hypertonic saline offers promise as a treatment for IH. Current research seems to support
its effectiveness in reducing intracranial pressures. Each patients co-morbidities and
expected results before choosing an osmotic therapy is an important consideration.
Whether used as an initial treatment for elevated intracranial pressure or as a rescue
therapy for refractory IH, HS appears to offer an additional means for lowering ICP and
may provide a bridge to surgical decompression.
-
8/6/2019 Hyper Tonic Saline in the Treatment of Intracranial Hypertension
14/19
Correspondence to
Laura J Griffin, MSN, APRN, CCRN, ACNP-BC
Doctor of Nursing Practice Candidate
The University of Texas Health Science Center at Houston
School of Nursing
Houston, Texas
References
1. Frank J, Rosengart A: Intracranial pressure: monitoring and management. In Principles
of critical care. NewYork: McGraw Hill; 2005 Retrieved on March 20, 2010 from
http://online.statref.com/document.aspx?fxid=70&docid=606 (s)
2. Brain Trauma Foundation, American Association of Neurological Surgeons, Congress
of Neurological Surgeons: Guidelines for the management of severe traumatic brain
injury. J Neurotrauma; 2007; 24(S): S14-S20. (s)
3. Hickey JV: The clinical practice of neurological and neurosurgical nursing (6th ed.).
Philadelphia: Lippincott Williams & Wilkins; 2009. (s)
4. Qureshi AI, Suarez JI: Use of hypertonic saline solutions in treatment of cerebral
edema and intracranial hypertension. Crit Care Med; 2000; 28(9): 3301-3313. (s)
5. Weed L, McKibben P: Experimental alteration of brain bulk. Am J Physiol; 1919; 48:
531-555. (s)
6. Vassar MJ, Perry CA, Gannaway WL, Holcroft JW: 7.5% sodium chloride/dextran forresuscitation of trauma patients undergoing helicopter transport. Arch Surg; 1991;
126(9): 1065-1072. (s)
7. Vassar MJ, Fischer RP, O'Brien PE, Bachulis BL, Chambers JA, Hoyt DB, Holcroft, J:
A multicenter trial for resuscitation of injured patients with 7.5% sodium chloride. The
http://scholar.google.ca/scholar?q=Frank%2BJ%2C%2BRosengart%2BA%3A%2BIntracranial%2Bpressure%3A%2Bmonitoring%2Band%2Bmanagement.%2BIn%2BPrinciples%2Bof%2Bcritical%2Bcare.%2BNewYork%3A%2BMcGraw%2BHill%3B%2B2005%2BRetrieved%2Bon%2BMarch%2B20%2C%2B2010%2Bfrom%2Bhttp%3A%2F%2Fonline.statref.com%2Fdocument.aspx%3Ffxid%3D70%26amp%3Bdocid%3D606%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Brain%2BTrauma%2BFoundation%2C%2BAmerican%2BAssociation%2Bof%2BNeurological%2BSurgeons%2C%2BCongress%2Bof%2BNeurological%2BSurgeons%3A%2BGuidelines%2Bfor%2Bthe%2Bmanagement%2Bof%2Bsevere%2Btraumatic%2Bbrain%2Binjury.%2BJ%2BNeurotrauma%3B%2B2007%3B%2B24(S)%3A%2BS14-S20.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Hickey%2BJV%3A%2BThe%2Bclinical%2Bpractice%2Bof%2Bneurological%2Band%2Bneurosurgical%2Bnursing%2B(6th%2Bed.).%2BPhiladelphia%3A%2BLippincott%2BWilliams%2B%26amp%3B%2BWilkins%3B%2B2009.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Qureshi%2BAI%2C%2BSuarez%2BJI%3A%2BUse%2Bof%2Bhypertonic%2Bsaline%2Bsolutions%2Bin%2Btreatment%2Bof%2Bcerebral%2Bedema%2Band%2Bintracranial%2Bhypertension.%2BCrit%2BCare%2BMed%3B%2B2000%3B%2B28(9)%3A%2B3301-3313.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Weed%2BL%2C%2BMcKibben%2BP%3A%2BExperimental%2Balteration%2Bof%2Bbrain%2Bbulk.%2BAm%2BJ%2BPhysiol%3B%2B1919%3B%2B48%3A%2B531-555.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Vassar%2BMJ%2C%2BPerry%2BCA%2C%2BGannaway%2BWL%2C%2BHolcroft%2BJW%3A%2B7.5%25%2Bsodium%2Bchloride%2Fdextran%2Bfor%2Bresuscitation%2Bof%2Btrauma%2Bpatients%2Bundergoing%2Bhelicopter%2Btransport.%2BArch%2BSurg%3B%2B1991%3B%2B126(9)%3A%2B1065-1072.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Frank%2BJ%2C%2BRosengart%2BA%3A%2BIntracranial%2Bpressure%3A%2Bmonitoring%2Band%2Bmanagement.%2BIn%2BPrinciples%2Bof%2Bcritical%2Bcare.%2BNewYork%3A%2BMcGraw%2BHill%3B%2B2005%2BRetrieved%2Bon%2BMarch%2B20%2C%2B2010%2Bfrom%2Bhttp%3A%2F%2Fonline.statref.com%2Fdocument.aspx%3Ffxid%3D70%26amp%3Bdocid%3D606%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Brain%2BTrauma%2BFoundation%2C%2BAmerican%2BAssociation%2Bof%2BNeurological%2BSurgeons%2C%2BCongress%2Bof%2BNeurological%2BSurgeons%3A%2BGuidelines%2Bfor%2Bthe%2Bmanagement%2Bof%2Bsevere%2Btraumatic%2Bbrain%2Binjury.%2BJ%2BNeurotrauma%3B%2B2007%3B%2B24(S)%3A%2BS14-S20.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Hickey%2BJV%3A%2BThe%2Bclinical%2Bpractice%2Bof%2Bneurological%2Band%2Bneurosurgical%2Bnursing%2B(6th%2Bed.).%2BPhiladelphia%3A%2BLippincott%2BWilliams%2B%26amp%3B%2BWilkins%3B%2B2009.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Qureshi%2BAI%2C%2BSuarez%2BJI%3A%2BUse%2Bof%2Bhypertonic%2Bsaline%2Bsolutions%2Bin%2Btreatment%2Bof%2Bcerebral%2Bedema%2Band%2Bintracranial%2Bhypertension.%2BCrit%2BCare%2BMed%3B%2B2000%3B%2B28(9)%3A%2B3301-3313.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Weed%2BL%2C%2BMcKibben%2BP%3A%2BExperimental%2Balteration%2Bof%2Bbrain%2Bbulk.%2BAm%2BJ%2BPhysiol%3B%2B1919%3B%2B48%3A%2B531-555.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Vassar%2BMJ%2C%2BPerry%2BCA%2C%2BGannaway%2BWL%2C%2BHolcroft%2BJW%3A%2B7.5%25%2Bsodium%2Bchloride%2Fdextran%2Bfor%2Bresuscitation%2Bof%2Btrauma%2Bpatients%2Bundergoing%2Bhelicopter%2Btransport.%2BArch%2BSurg%3B%2B1991%3B%2B126(9)%3A%2B1065-1072.%0A&hl=en&lr=&btnG=Search -
8/6/2019 Hyper Tonic Saline in the Treatment of Intracranial Hypertension
15/19
effect of added dextran 70. The multicenter group for the study of hypertonic saline in
trauma patients. Arch Surg; 1993; 128(9): 1003-1011. (s)
8. Centers for Disease Control. What is traumatic brain injury? Retrieved April 10, 2009
from http://www.cdc.gov/ncipc/tbi/TBI.htm. (s)
9. Oddo M, Levine JM, Frangos S, Carrera E, Maloney-Wilensky E, Pascual JL, Kofke
WA, Mayer SA, LeRoux, P: Effect of mannitol and hypertonic saline on cerebral
oxygenation in patients with severe traumatic brain injury and refractory intracranial
hypertension. J Neurol Neurosurg Psychiatry; 2009; 80 (8): 916-920. (s)
10. Vialet R, Albanese J, Thomachot L, Antonini F, Bourgouin A, Alliez B, Martin, C:
Isovolume hypertonic solutes (sodium chloride or mannitol) in the treatment of refractory
posttraumatic intracranial hypertension: 2 mL/kg 7.5% saline is more effective than 2
mL/kg 20% mannitol. Crit Care Med; 2003; 31(6): 1683-1687. (s)
11. Shackford SR, Bourguignon PR, Wald SL, Rogers FB, Osler TM, Clark DE:
Hypertonic saline resuscitation of patients with head injury: a prospective, randomized
clinical trial. J Trauma; 1998; 44(1): 50-58. (s)
12. Qureshi AI, Suarez JI, Castro A, Bhardwaj A: Use of hypertonic saline/acetate
infusion in treatment of cerebral edema in patients with head trauma: experience at a
single center. J Trauma; 1999; 47(4): 659-665. (s)
13. Lescot T, Degos V, Zouaoui A, Preteux F, Coriat P, Puybasset L: Opposed effects of
hypertonic saline on contusions and noncontused brain tissue in patients with severe
traumatic brain injury. Crit Care Med; 2006; 34(12): 3029-3033. (s)
14. Battison C, Andrews PJ, Graham C, Petty T: Randomized, controlled trial on the
effect of a 20% mannitol solution and a 7.5% saline/6% dextran solution on increased
intracranial pressure after brain injury. Critical Care Medicine; 2005; 33(1): 196-202. (s)
http://scholar.google.ca/scholar?q=Vassar%2BMJ%2C%2BFischer%2BRP%2C%2BO%27Brien%2BPE%2C%2BBachulis%2BBL%2C%2BChambers%2BJA%2C%2BHoyt%2BDB%2C%2BHolcroft%2C%2BJ%3A%2BA%2Bmulticenter%2Btrial%2Bfor%2Bresuscitation%2Bof%2Binjured%2Bpatients%2Bwith%2B7.5%25%2Bsodium%2Bchloride.%2BThe%2Beffect%2Bof%2Badded%2Bdextran%2B70.%2BThe%2Bmulticenter%2Bgroup%2Bfor%2Bthe%2Bstudy%2Bof%2Bhypertonic%2Bsaline%2Bin%2Btrauma%2Bpatients.%2BArch%2BSurg%3B%2B1993%3B%2B128(9)%3A%2B1003-1011.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Centers%2Bfor%2BDisease%2BControl.%2BWhat%2Bis%2Btraumatic%2Bbrain%2Binjury%3F%2BRetrieved%2BApril%2B10%2C%2B2009%2Bfrom%2Bhttp%3A%2F%2Fwww.cdc.gov%2Fncipc%2Ftbi%2FTBI.htm.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Oddo%2BM%2C%2BLevine%2BJM%2C%2BFrangos%2BS%2C%2BCarrera%2BE%2C%2BMaloney-Wilensky%2BE%2C%2BPascual%2BJL%2C%2BKofke%2BWA%2C%2BMayer%2BSA%2C%2BLeRoux%2C%2BP%3A%2BEffect%2Bof%2Bmannitol%2Band%2Bhypertonic%2Bsaline%2Bon%2Bcerebral%2Boxygenation%2Bin%2Bpatients%2Bwith%2Bsevere%2Btraumatic%2Bbrain%2Binjury%2Band%2Brefractory%2Bintracranial%2Bhypertension.%2BJ%2BNeurol%2BNeurosurg%2BPsychiatry%3B%2B2009%3B%2B80%2B(8)%3A%2B916-920.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Vialet%2BR%2C%2BAlbanese%2BJ%2C%2BThomachot%2BL%2C%2BAntonini%2BF%2C%2BBourgouin%2BA%2C%2BAlliez%2BB%2C%2BMartin%2C%2BC%3A%2BIsovolume%2Bhypertonic%2Bsolutes%2B(sodium%2Bchloride%2Bor%2Bmannitol)%2Bin%2Bthe%2Btreatment%2Bof%2Brefractory%2Bposttraumatic%2Bintracranial%2Bhypertension%3A%2B2%2BmL%2Fkg%2B7.5%25%2Bsaline%2Bis%2Bmore%2Beffective%2Bthan%2B2%2BmL%2Fkg%2B20%25%2Bmannitol.%2BCrit%2BCare%2BMed%3B%2B2003%3B%2B31(6)%3A%2B1683-1687.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Shackford%2BSR%2C%2BBourguignon%2BPR%2C%2BWald%2BSL%2C%2BRogers%2BFB%2C%2BOsler%2BTM%2C%2BClark%2BDE%3A%2BHypertonic%2Bsaline%2Bresuscitation%2Bof%2Bpatients%2Bwith%2Bhead%2Binjury%3A%2Ba%2Bprospective%2C%2Brandomized%2Bclinical%2Btrial.%2BJ%2BTrauma%3B%2B1998%3B%2B44(1)%3A%2B50-58.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Qureshi%2BAI%2C%2BSuarez%2BJI%2C%2BCastro%2BA%2C%2BBhardwaj%2BA%3A%2BUse%2Bof%2Bhypertonic%2Bsaline%2Facetate%2Binfusion%2Bin%2Btreatment%2Bof%2Bcerebral%2Bedema%2Bin%2Bpatients%2Bwith%2Bhead%2Btrauma%3A%2Bexperience%2Bat%2Ba%2Bsingle%2Bcenter.%2BJ%2BTrauma%3B%2B1999%3B%2B47(4)%3A%2B659-665.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Lescot%2BT%2C%2BDegos%2BV%2C%2BZouaoui%2BA%2C%2BPreteux%2BF%2C%2BCoriat%2BP%2C%2BPuybasset%2BL%3A%2BOpposed%2Beffects%2Bof%2Bhypertonic%2Bsaline%2Bon%2Bcontusions%2Band%2Bnoncontused%2Bbrain%2Btissue%2Bin%2Bpatients%2Bwith%2Bsevere%2Btraumatic%2Bbrain%2Binjury.%2BCrit%2BCare%2BMed%3B%2B2006%3B%2B34(12)%3A%2B3029-3033.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Battison%2BC%2C%2BAndrews%2BPJ%2C%2BGraham%2BC%2C%2BPetty%2BT%3A%2BRandomized%2C%2Bcontrolled%2Btrial%2Bon%2Bthe%2Beffect%2Bof%2Ba%2B20%25%2Bmannitol%2Bsolution%2Band%2Ba%2B7.5%25%2Bsaline%2F6%25%2Bdextran%2Bsolution%2Bon%2Bincreased%2Bintracranial%2Bpressure%2Bafter%2Bbrain%2Binjury.%2BCritical%2BCare%2BMedicine%3B%2B2005%3B%2B33(1)%3A%2B196-202.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Vassar%2BMJ%2C%2BFischer%2BRP%2C%2BO%27Brien%2BPE%2C%2BBachulis%2BBL%2C%2BChambers%2BJA%2C%2BHoyt%2BDB%2C%2BHolcroft%2C%2BJ%3A%2BA%2Bmulticenter%2Btrial%2Bfor%2Bresuscitation%2Bof%2Binjured%2Bpatients%2Bwith%2B7.5%25%2Bsodium%2Bchloride.%2BThe%2Beffect%2Bof%2Badded%2Bdextran%2B70.%2BThe%2Bmulticenter%2Bgroup%2Bfor%2Bthe%2Bstudy%2Bof%2Bhypertonic%2Bsaline%2Bin%2Btrauma%2Bpatients.%2BArch%2BSurg%3B%2B1993%3B%2B128(9)%3A%2B1003-1011.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Centers%2Bfor%2BDisease%2BControl.%2BWhat%2Bis%2Btraumatic%2Bbrain%2Binjury%3F%2BRetrieved%2BApril%2B10%2C%2B2009%2Bfrom%2Bhttp%3A%2F%2Fwww.cdc.gov%2Fncipc%2Ftbi%2FTBI.htm.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Oddo%2BM%2C%2BLevine%2BJM%2C%2BFrangos%2BS%2C%2BCarrera%2BE%2C%2BMaloney-Wilensky%2BE%2C%2BPascual%2BJL%2C%2BKofke%2BWA%2C%2BMayer%2BSA%2C%2BLeRoux%2C%2BP%3A%2BEffect%2Bof%2Bmannitol%2Band%2Bhypertonic%2Bsaline%2Bon%2Bcerebral%2Boxygenation%2Bin%2Bpatients%2Bwith%2Bsevere%2Btraumatic%2Bbrain%2Binjury%2Band%2Brefractory%2Bintracranial%2Bhypertension.%2BJ%2BNeurol%2BNeurosurg%2BPsychiatry%3B%2B2009%3B%2B80%2B(8)%3A%2B916-920.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Vialet%2BR%2C%2BAlbanese%2BJ%2C%2BThomachot%2BL%2C%2BAntonini%2BF%2C%2BBourgouin%2BA%2C%2BAlliez%2BB%2C%2BMartin%2C%2BC%3A%2BIsovolume%2Bhypertonic%2Bsolutes%2B(sodium%2Bchloride%2Bor%2Bmannitol)%2Bin%2Bthe%2Btreatment%2Bof%2Brefractory%2Bposttraumatic%2Bintracranial%2Bhypertension%3A%2B2%2BmL%2Fkg%2B7.5%25%2Bsaline%2Bis%2Bmore%2Beffective%2Bthan%2B2%2BmL%2Fkg%2B20%25%2Bmannitol.%2BCrit%2BCare%2BMed%3B%2B2003%3B%2B31(6)%3A%2B1683-1687.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Shackford%2BSR%2C%2BBourguignon%2BPR%2C%2BWald%2BSL%2C%2BRogers%2BFB%2C%2BOsler%2BTM%2C%2BClark%2BDE%3A%2BHypertonic%2Bsaline%2Bresuscitation%2Bof%2Bpatients%2Bwith%2Bhead%2Binjury%3A%2Ba%2Bprospective%2C%2Brandomized%2Bclinical%2Btrial.%2BJ%2BTrauma%3B%2B1998%3B%2B44(1)%3A%2B50-58.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Qureshi%2BAI%2C%2BSuarez%2BJI%2C%2BCastro%2BA%2C%2BBhardwaj%2BA%3A%2BUse%2Bof%2Bhypertonic%2Bsaline%2Facetate%2Binfusion%2Bin%2Btreatment%2Bof%2Bcerebral%2Bedema%2Bin%2Bpatients%2Bwith%2Bhead%2Btrauma%3A%2Bexperience%2Bat%2Ba%2Bsingle%2Bcenter.%2BJ%2BTrauma%3B%2B1999%3B%2B47(4)%3A%2B659-665.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Lescot%2BT%2C%2BDegos%2BV%2C%2BZouaoui%2BA%2C%2BPreteux%2BF%2C%2BCoriat%2BP%2C%2BPuybasset%2BL%3A%2BOpposed%2Beffects%2Bof%2Bhypertonic%2Bsaline%2Bon%2Bcontusions%2Band%2Bnoncontused%2Bbrain%2Btissue%2Bin%2Bpatients%2Bwith%2Bsevere%2Btraumatic%2Bbrain%2Binjury.%2BCrit%2BCare%2BMed%3B%2B2006%3B%2B34(12)%3A%2B3029-3033.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Battison%2BC%2C%2BAndrews%2BPJ%2C%2BGraham%2BC%2C%2BPetty%2BT%3A%2BRandomized%2C%2Bcontrolled%2Btrial%2Bon%2Bthe%2Beffect%2Bof%2Ba%2B20%25%2Bmannitol%2Bsolution%2Band%2Ba%2B7.5%25%2Bsaline%2F6%25%2Bdextran%2Bsolution%2Bon%2Bincreased%2Bintracranial%2Bpressure%2Bafter%2Bbrain%2Binjury.%2BCritical%2BCare%2BMedicine%3B%2B2005%3B%2B33(1)%3A%2B196-202.%0A&hl=en&lr=&btnG=Search -
8/6/2019 Hyper Tonic Saline in the Treatment of Intracranial Hypertension
16/19
15. Francony G, Fauvage B, Falcon D, Canet C, Dilou H, Lavagne P, Jacquot C, Payen J:
Equimolar doses of mannitol and hypertonic saline in the treatment of increased
intracranial pressure. Crit Care Med; 2008;36(3): 795-800. (s)
16. Koenig MA, Bryan M, Lewin JL, Mirski MA, Geocadin RG, Stevens RD: Reversal
of transtentorial herniation with hypertonic saline. Neurology; 2008; 70(13): 1023-1029.
(s)
17. Bentsen G, Breivik H, Lundar T, Stubhaug A: Predictable reduction of intracranial
hypertension with hypertonic saline hydroxyethyl starch: a prospective clinical trial in
critically ill patients with subarachnoid haemorrhage. Acta Anaesthesiol Scand; 2004;
48(9): 1089-1095. (s)
18. Bentsen G, Breivik H, Lundar T, Stubhaug A: Hypertonic saline (7.2%) in 6%
hydroxyethyl starch reduces intracranial pressure and improves hemodynamics in a
placebo-controlled study involving stable patients with subarachnoid hemorrhage. Crit
Care Med: 2006; 34(12): 2912-2917. (s)
19. Tseng MY, Al-Rawi PG, Czosnyka M, Hutchinson PJ, Richards H, Pickard JD.
Kirkpatrick PJ: Enhancement of cerebral blood flow using systemic hypertonic saline
therapy improves outcome in patients with poor-grade spontaneous subarachnoid
hemorrhage. J Neurosurg; 2007; 107(2): 274-282. (s)
20. Tseng MY, Al-Rawi PG, Pickard JD, Rasulo FA, Kirkpatrick PJ: Effect of hypertonic
saline on cerebral blood flow in poor-grade patients with subarachnoid hemorrhage.
Stroke; 2003; 34(6): 1389-1396. (s)
21. Schwarz S, Schwab S, Bertram M, Aschoff A, Hacke W: Effects of hypertonic saline
hydroxyethyl starch solution and mannitol in patients with increased intracranial pressure
after stroke. Stroke; 1998; 29(8): 1550-1555. (s)
22. Schwarz S, Georgiadis D, Aschoff A, Schwab S: Effects of hypertonic (10%) saline
in patients with raised intracranial pressure after stroke. Stroke; 2002; 33(1): 136-140. (s)
http://scholar.google.ca/scholar?q=Francony%2BG%2C%2BFauvage%2BB%2C%2BFalcon%2BD%2C%2BCanet%2BC%2C%2BDilou%2BH%2C%2BLavagne%2BP%2C%2BJacquot%2BC%2C%2BPayen%2BJ%3A%2BEquimolar%2Bdoses%2Bof%2Bmannitol%2Band%2Bhypertonic%2Bsaline%2Bin%2Bthe%2Btreatment%2Bof%2Bincreased%2Bintracranial%2Bpressure.%2BCrit%2BCare%2BMed%3B%2B2008%3B36(3)%3A%2B795-800.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Koenig%2BMA%2C%2BBryan%2BM%2C%2BLewin%2BJL%2C%2BMirski%2BMA%2C%2BGeocadin%2BRG%2C%2BStevens%2BRD%3A%2BReversal%2Bof%2Btranstentorial%2Bherniation%2Bwith%2Bhypertonic%2Bsaline.%2BNeurology%3B%2B2008%3B%2B70(13)%3A%2B1023-1029.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Bentsen%2BG%2C%2BBreivik%2BH%2C%2BLundar%2BT%2C%2BStubhaug%2BA%3A%2BPredictable%2Breduction%2Bof%2Bintracranial%2Bhypertension%2Bwith%2Bhypertonic%2Bsaline%2Bhydroxyethyl%2Bstarch%3A%2Ba%2Bprospective%2Bclinical%2Btrial%2Bin%2Bcritically%2Bill%2Bpatients%2Bwith%2Bsubarachnoid%2Bhaemorrhage.%2BActa%2BAnaesthesiol%2BScand%3B%2B2004%3B%2B48(9)%3A%2B1089-1095.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Bentsen%2BG%2C%2BBreivik%2BH%2C%2BLundar%2BT%2C%2BStubhaug%2BA%3A%2BHypertonic%2Bsaline%2B(7.2%25)%2Bin%2B6%25%2Bhydroxyethyl%2Bstarch%2Breduces%2Bintracranial%2Bpressure%2Band%2Bimproves%2Bhemodynamics%2Bin%2Ba%2Bplacebo-controlled%2Bstudy%2Binvolving%2Bstable%2Bpatients%2Bwith%2Bsubarachnoid%2Bhemorrhage.%2BCrit%2BCare%2BMed%3A%2B2006%3B%2B34(12)%3A%2B2912-2917.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Tseng%2BMY%2C%2BAl-Rawi%2BPG%2C%2BCzosnyka%2BM%2C%2BHutchinson%2BPJ%2C%2BRichards%2BH%2C%2BPickard%2BJD.%2BKirkpatrick%2BPJ%3A%2BEnhancement%2Bof%2Bcerebral%2Bblood%2Bflow%2Busing%2Bsystemic%2Bhypertonic%2Bsaline%2Btherapy%2Bimproves%2Boutcome%2Bin%2Bpatients%2Bwith%2Bpoor-grade%2Bspontaneous%2Bsubarachnoid%2Bhemorrhage.%2BJ%2BNeurosurg%3B%2B2007%3B%2B107(2)%3A%2B274-282.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Tseng%2BMY%2C%2BAl-Rawi%2BPG%2C%2BPickard%2BJD%2C%2BRasulo%2BFA%2C%2BKirkpatrick%2BPJ%3A%2BEffect%2Bof%2Bhypertonic%2Bsaline%2Bon%2Bcerebral%2Bblood%2Bflow%2Bin%2Bpoor-grade%2Bpatients%2Bwith%2Bsubarachnoid%2Bhemorrhage.%2BStroke%3B%2B2003%3B%2B34(6)%3A%2B1389-1396.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Schwarz%2BS%2C%2BSchwab%2BS%2C%2BBertram%2BM%2C%2BAschoff%2BA%2C%2BHacke%2BW%3A%2BEffects%2Bof%2Bhypertonic%2Bsaline%2Bhydroxyethyl%2Bstarch%2Bsolution%2Band%2Bmannitol%2Bin%2Bpatients%2Bwith%2Bincreased%2Bintracranial%2Bpressure%2Bafter%2Bstroke.%2BStroke%3B%2B1998%3B%2B29(8)%3A%2B1550-1555.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Schwarz%2BS%2C%2BGeorgiadis%2BD%2C%2BAschoff%2BA%2C%2BSchwab%2BS%3A%2BEffects%2Bof%2Bhypertonic%2B(10%25)%2Bsaline%2Bin%2Bpatients%2Bwith%2Braised%2Bintracranial%2Bpressure%2Bafter%2Bstroke.%2BStroke%3B%2B2002%3B%2B33(1)%3A%2B136-140.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Francony%2BG%2C%2BFauvage%2BB%2C%2BFalcon%2BD%2C%2BCanet%2BC%2C%2BDilou%2BH%2C%2BLavagne%2BP%2C%2BJacquot%2BC%2C%2BPayen%2BJ%3A%2BEquimolar%2Bdoses%2Bof%2Bmannitol%2Band%2Bhypertonic%2Bsaline%2Bin%2Bthe%2Btreatment%2Bof%2Bincreased%2Bintracranial%2Bpressure.%2BCrit%2BCare%2BMed%3B%2B2008%3B36(3)%3A%2B795-800.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Koenig%2BMA%2C%2BBryan%2BM%2C%2BLewin%2BJL%2C%2BMirski%2BMA%2C%2BGeocadin%2BRG%2C%2BStevens%2BRD%3A%2BReversal%2Bof%2Btranstentorial%2Bherniation%2Bwith%2Bhypertonic%2Bsaline.%2BNeurology%3B%2B2008%3B%2B70(13)%3A%2B1023-1029.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Bentsen%2BG%2C%2BBreivik%2BH%2C%2BLundar%2BT%2C%2BStubhaug%2BA%3A%2BPredictable%2Breduction%2Bof%2Bintracranial%2Bhypertension%2Bwith%2Bhypertonic%2Bsaline%2Bhydroxyethyl%2Bstarch%3A%2Ba%2Bprospective%2Bclinical%2Btrial%2Bin%2Bcritically%2Bill%2Bpatients%2Bwith%2Bsubarachnoid%2Bhaemorrhage.%2BActa%2BAnaesthesiol%2BScand%3B%2B2004%3B%2B48(9)%3A%2B1089-1095.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Bentsen%2BG%2C%2BBreivik%2BH%2C%2BLundar%2BT%2C%2BStubhaug%2BA%3A%2BHypertonic%2Bsaline%2B(7.2%25)%2Bin%2B6%25%2Bhydroxyethyl%2Bstarch%2Breduces%2Bintracranial%2Bpressure%2Band%2Bimproves%2Bhemodynamics%2Bin%2Ba%2Bplacebo-controlled%2Bstudy%2Binvolving%2Bstable%2Bpatients%2Bwith%2Bsubarachnoid%2Bhemorrhage.%2BCrit%2BCare%2BMed%3A%2B2006%3B%2B34(12)%3A%2B2912-2917.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Tseng%2BMY%2C%2BAl-Rawi%2BPG%2C%2BCzosnyka%2BM%2C%2BHutchinson%2BPJ%2C%2BRichards%2BH%2C%2BPickard%2BJD.%2BKirkpatrick%2BPJ%3A%2BEnhancement%2Bof%2Bcerebral%2Bblood%2Bflow%2Busing%2Bsystemic%2Bhypertonic%2Bsaline%2Btherapy%2Bimproves%2Boutcome%2Bin%2Bpatients%2Bwith%2Bpoor-grade%2Bspontaneous%2Bsubarachnoid%2Bhemorrhage.%2BJ%2BNeurosurg%3B%2B2007%3B%2B107(2)%3A%2B274-282.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Tseng%2BMY%2C%2BAl-Rawi%2BPG%2C%2BPickard%2BJD%2C%2BRasulo%2BFA%2C%2BKirkpatrick%2BPJ%3A%2BEffect%2Bof%2Bhypertonic%2Bsaline%2Bon%2Bcerebral%2Bblood%2Bflow%2Bin%2Bpoor-grade%2Bpatients%2Bwith%2Bsubarachnoid%2Bhemorrhage.%2BStroke%3B%2B2003%3B%2B34(6)%3A%2B1389-1396.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Schwarz%2BS%2C%2BSchwab%2BS%2C%2BBertram%2BM%2C%2BAschoff%2BA%2C%2BHacke%2BW%3A%2BEffects%2Bof%2Bhypertonic%2Bsaline%2Bhydroxyethyl%2Bstarch%2Bsolution%2Band%2Bmannitol%2Bin%2Bpatients%2Bwith%2Bincreased%2Bintracranial%2Bpressure%2Bafter%2Bstroke.%2BStroke%3B%2B1998%3B%2B29(8)%3A%2B1550-1555.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Schwarz%2BS%2C%2BGeorgiadis%2BD%2C%2BAschoff%2BA%2C%2BSchwab%2BS%3A%2BEffects%2Bof%2Bhypertonic%2B(10%25)%2Bsaline%2Bin%2Bpatients%2Bwith%2Braised%2Bintracranial%2Bpressure%2Bafter%2Bstroke.%2BStroke%3B%2B2002%3B%2B33(1)%3A%2B136-140.%0A&hl=en&lr=&btnG=Search -
8/6/2019 Hyper Tonic Saline in the Treatment of Intracranial Hypertension
17/19
23. Munar F, Ferrer AM, de Nadal M, Poca MA, Pedraza S, Sahuquillo J, Garnacho A:
Cerebral hemodynamic effects of 7.2% hypertonic saline in patients with head injury and
raised intracranial pressure. J Neurotrauma; 2000; 17(1): 41-51. (s)
24. Suarez JI, Qureshi AI, Bhardwaj A, Williams MA, Schnitzer MS, Mirski M, Hanely
DF, Ulatowski, J: Treatment of refractory intracranial hypertension with 23.4% saline.
Crit Care Med: 1998; 26(6): 1118-1122. (s)
25. Froelich M, Ni Q, Wess C, Ougorets I, Hartl R: Continuous hypertonic saline therapy
and the occurrence of complications in neurocritically ill patients. Crit Care Med: 2009;
37(4): 1433-1441. (s)
26. Huang SJ, Chang L, Han YY, Lee YC, Tu YK: Efficacy and safety of hypertonic
saline solutions in the treatment of severe head injury. Surg Neurol; 2006; 65(6): 539-
546. (s)
27. Reed RL, Johnston TD, Chen Y, Fischer RP: Hypertonic saline alters plasma clotting
times and platelet aggregation. J Trauma; 1991; 31(1): 8-14. (s)
28. Hess JR, Dubick MA, Summary JJ, Bangal NR, Wade CE: The effects of 7.5%
NaCl/6% dextran 70 on coagulation and platelet aggregation in humans. J Trauma; 1992;
32(1): 40-44. (s)
29. Horn P, Munch E, Vajkoczy P, Herrmann P, Quintel M, Schilling L, Schmledek P,
Shurer L: Hypertonic saline solution for control of elevated intracranial pressure in
patients with exhausted response to mannitol and barbiturates. Neurol Res; 1999; 21(8):
758-764. (s)
30. Ichai C, Armando G, Orban J, Berthier F, Rami L, Samat-Long C, Grimaud D,
Leverve X: Sodium lactate versus mannitol in the treatment of intracranial hypertensive
episodes in severe traumatic brain-injured patients. Intensive Care Med: 2009; 35: 471-
479. (s)
http://scholar.google.ca/scholar?q=Munar%2BF%2C%2BFerrer%2BAM%2C%2Bde%2BNadal%2BM%2C%2BPoca%2BMA%2C%2BPedraza%2BS%2C%2BSahuquillo%2BJ%2C%2BGarnacho%2BA%3A%2BCerebral%2Bhemodynamic%2Beffects%2Bof%2B7.2%25%2Bhypertonic%2Bsaline%2Bin%2Bpatients%2Bwith%2Bhead%2Binjury%2Band%2Braised%2Bintracranial%2Bpressure.%2BJ%2BNeurotrauma%3B%2B2000%3B%2B17(1)%3A%2B41-51.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Suarez%2BJI%2C%2BQureshi%2BAI%2C%2BBhardwaj%2BA%2C%2BWilliams%2BMA%2C%2BSchnitzer%2BMS%2C%2BMirski%2BM%2C%2BHanely%2BDF%2C%2BUlatowski%2C%2BJ%3A%2BTreatment%2Bof%2Brefractory%2Bintracranial%2Bhypertension%2Bwith%2B23.4%25%2Bsaline.%2BCrit%2BCare%2BMed%3A%2B1998%3B%2B26(6)%3A%2B1118-1122.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Froelich%2BM%2C%2BNi%2BQ%2C%2BWess%2BC%2C%2BOugorets%2BI%2C%2BHartl%2BR%3A%2BContinuous%2Bhypertonic%2Bsaline%2Btherapy%2Band%2Bthe%2Boccurrence%2Bof%2Bcomplications%2Bin%2Bneurocritically%2Bill%2Bpatients.%2BCrit%2BCare%2BMed%3A%2B2009%3B%2B37(4)%3A%2B1433-1441.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Huang%2BSJ%2C%2BChang%2BL%2C%2BHan%2BYY%2C%2BLee%2BYC%2C%2BTu%2BYK%3A%2BEfficacy%2Band%2Bsafety%2Bof%2Bhypertonic%2Bsaline%2Bsolutions%2Bin%2Bthe%2Btreatment%2Bof%2Bsevere%2Bhead%2Binjury.%2BSurg%2BNeurol%3B%2B2006%3B%2B65(6)%3A%2B539-546.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Reed%2BRL%2C%2BJohnston%2BTD%2C%2BChen%2BY%2C%2BFischer%2BRP%3A%2BHypertonic%2Bsaline%2Balters%2Bplasma%2Bclotting%2Btimes%2Band%2Bplatelet%2Baggregation.%2BJ%2BTrauma%3B%2B1991%3B%2B31(1)%3A%2B8-14.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Hess%2BJR%2C%2BDubick%2BMA%2C%2BSummary%2BJJ%2C%2BBangal%2BNR%2C%2BWade%2BCE%3A%2BThe%2Beffects%2Bof%2B7.5%25%2BNaCl%2F6%25%2Bdextran%2B70%2Bon%2Bcoagulation%2Band%2Bplatelet%2Baggregation%2Bin%2Bhumans.%2BJ%2BTrauma%3B%2B1992%3B%2B32(1)%3A%2B40-44.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Horn%2BP%2C%2BMunch%2BE%2C%2BVajkoczy%2BP%2C%2BHerrmann%2BP%2C%2BQuintel%2BM%2C%2BSchilling%2BL%2C%2BSchmledek%2BP%2C%2BShurer%2BL%3A%2BHypertonic%2Bsaline%2Bsolution%2Bfor%2Bcontrol%2Bof%2Belevated%2Bintracranial%2Bpressure%2Bin%2Bpatients%2Bwith%2Bexhausted%2Bresponse%2Bto%2Bmannitol%2Band%2Bbarbiturates.%2BNeurol%2BRes%3B%2B1999%3B%2B21(8)%3A%2B758-764.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Ichai%2BC%2C%2BArmando%2BG%2C%2BOrban%2BJ%2C%2BBerthier%2BF%2C%2BRami%2BL%2C%2BSamat-Long%2BC%2C%2BGrimaud%2BD%2C%2BLeverve%2BX%3A%2BSodium%2Blactate%2Bversus%2Bmannitol%2Bin%2Bthe%2Btreatment%2Bof%2Bintracranial%2Bhypertensive%2Bepisodes%2Bin%2Bsevere%2Btraumatic%2Bbrain-injured%2Bpatients.%2BIntensive%2BCare%2BMed%3A%2B2009%3B%2B35%3A%2B471-479.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Munar%2BF%2C%2BFerrer%2BAM%2C%2Bde%2BNadal%2BM%2C%2BPoca%2BMA%2C%2BPedraza%2BS%2C%2BSahuquillo%2BJ%2C%2BGarnacho%2BA%3A%2BCerebral%2Bhemodynamic%2Beffects%2Bof%2B7.2%25%2Bhypertonic%2Bsaline%2Bin%2Bpatients%2Bwith%2Bhead%2Binjury%2Band%2Braised%2Bintracranial%2Bpressure.%2BJ%2BNeurotrauma%3B%2B2000%3B%2B17(1)%3A%2B41-51.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Suarez%2BJI%2C%2BQureshi%2BAI%2C%2BBhardwaj%2BA%2C%2BWilliams%2BMA%2C%2BSchnitzer%2BMS%2C%2BMirski%2BM%2C%2BHanely%2BDF%2C%2BUlatowski%2C%2BJ%3A%2BTreatment%2Bof%2Brefractory%2Bintracranial%2Bhypertension%2Bwith%2B23.4%25%2Bsaline.%2BCrit%2BCare%2BMed%3A%2B1998%3B%2B26(6)%3A%2B1118-1122.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Froelich%2BM%2C%2BNi%2BQ%2C%2BWess%2BC%2C%2BOugorets%2BI%2C%2BHartl%2BR%3A%2BContinuous%2Bhypertonic%2Bsaline%2Btherapy%2Band%2Bthe%2Boccurrence%2Bof%2Bcomplications%2Bin%2Bneurocritically%2Bill%2Bpatients.%2BCrit%2BCare%2BMed%3A%2B2009%3B%2B37(4)%3A%2B1433-1441.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Huang%2BSJ%2C%2BChang%2BL%2C%2BHan%2BYY%2C%2BLee%2BYC%2C%2BTu%2BYK%3A%2BEfficacy%2Band%2Bsafety%2Bof%2Bhypertonic%2Bsaline%2Bsolutions%2Bin%2Bthe%2Btreatment%2Bof%2Bsevere%2Bhead%2Binjury.%2BSurg%2BNeurol%3B%2B2006%3B%2B65(6)%3A%2B539-546.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Reed%2BRL%2C%2BJohnston%2BTD%2C%2BChen%2BY%2C%2BFischer%2BRP%3A%2BHypertonic%2Bsaline%2Balters%2Bplasma%2Bclotting%2Btimes%2Band%2Bplatelet%2Baggregation.%2BJ%2BTrauma%3B%2B1991%3B%2B31(1)%3A%2B8-14.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Hess%2BJR%2C%2BDubick%2BMA%2C%2BSummary%2BJJ%2C%2BBangal%2BNR%2C%2BWade%2BCE%3A%2BThe%2Beffects%2Bof%2B7.5%25%2BNaCl%2F6%25%2Bdextran%2B70%2Bon%2Bcoagulation%2Band%2Bplatelet%2Baggregation%2Bin%2Bhumans.%2BJ%2BTrauma%3B%2B1992%3B%2B32(1)%3A%2B40-44.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Horn%2BP%2C%2BMunch%2BE%2C%2BVajkoczy%2BP%2C%2BHerrmann%2BP%2C%2BQuintel%2BM%2C%2BSchilling%2BL%2C%2BSchmledek%2BP%2C%2BShurer%2BL%3A%2BHypertonic%2Bsaline%2Bsolution%2Bfor%2Bcontrol%2Bof%2Belevated%2Bintracranial%2Bpressure%2Bin%2Bpatients%2Bwith%2Bexhausted%2Bresponse%2Bto%2Bmannitol%2Band%2Bbarbiturates.%2BNeurol%2BRes%3B%2B1999%3B%2B21(8)%3A%2B758-764.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Ichai%2BC%2C%2BArmando%2BG%2C%2BOrban%2BJ%2C%2BBerthier%2BF%2C%2BRami%2BL%2C%2BSamat-Long%2BC%2C%2BGrimaud%2BD%2C%2BLeverve%2BX%3A%2BSodium%2Blactate%2Bversus%2Bmannitol%2Bin%2Bthe%2Btreatment%2Bof%2Bintracranial%2Bhypertensive%2Bepisodes%2Bin%2Bsevere%2Btraumatic%2Bbrain-injured%2Bpatients.%2BIntensive%2BCare%2BMed%3A%2B2009%3B%2B35%3A%2B471-479.%0A&hl=en&lr=&btnG=Search -
8/6/2019 Hyper Tonic Saline in the Treatment of Intracranial Hypertension
18/19
31. Kerwin A, Schinco M, Tepas J, Renfro W, Vitarbo E, Muehlberger M: The use of
23.4% hypertonic slaine for the management of elevated intracranial pressure in patients
with severe traumatic brain injury: a pilot study. J Trauma; 2009; 67: 277-282. (s)
32. Pascual JL, Maloney-Wilensky E, Reilly PM, Sicoutris C, Keutmann MK, Stein SC,
LeRoux PD, Gracias, VH: Resuscitation of hypotensive head-injured patients: is
hypertonic saline the answer? Am Surg; 2008; 74(3): 253-259. (s)
33. Hartl R, Ghajar J, Hochleuthner H, Mauritz W: Hypertonic/hyperoncotic saline
reliably reduces ICP in severely head-injured patients with intracranial hypertension.
Acta Neurochir Suppl; 1997; 70: 126-129. (s)
34. Hartl R, Ghajar J, Hochleuthner H, Mauritz W: Treatment of refractory intracranial
hypertension in severe traumatic brain injury with repetitive hypertonic/hyperoncotic
infusions. Zentralbl Chir; 1997; 122(3): 181-185. (s)
35. Harutjunyan L, Holz C, Rieger A, Menzel M, Grond S, Soukup J: Efficiency of 7.2%
hypertonic saline hydroxyethyl starch 200/0.5 versus mannitol 15% in the treatment of
increased intracranial pressure in neurosurgical patients - a randomized clinical trial. Crit
Care; 2005; 9(5): R530-40. (s)
36. Qureshi AI, Suarez JI, Bhardwaj A: Malignant cerebral edema in patients with
hypertensive intracerebral hemorrhage associated with hypertonic saline infusion: A
rebound phenomenon? Journal of Neurosurg Anesthesiol; 1998; 10(3): 188-192. (s)
37. Qureshi AI, Suarez JI, Bhardwaj A, Mirski M, Schnitzer MS, Hanley DF, Ulatowski,
J: Use of hypertonic (3%) saline/acetate infusion in the treatment of cerebral edema:
Effect on intracranial pressure and lateral displacement of the brain. Crit Care Med; 1998;
26(3): 440-446. (s)
38. Rockswold G, Solid C, Paredes-Andrade E, Rockswold S, Jancik J, Quickel R:
Hypertonic saline and its effect on intracranial pressure, cerebral perfusion pressure and
brain tissue oxygenation. Neurosurgery; 2009; 65: 1035-1042. (s)
http://scholar.google.ca/scholar?q=Kerwin%2BA%2C%2BSchinco%2BM%2C%2BTepas%2BJ%2C%2BRenfro%2BW%2C%2BVitarbo%2BE%2C%2BMuehlberger%2BM%3A%2BThe%2Buse%2Bof%2B23.4%25%2Bhypertonic%2Bslaine%2Bfor%2Bthe%2Bmanagement%2Bof%2Belevated%2Bintracranial%2Bpressure%2Bin%2Bpatients%2Bwith%2Bsevere%2Btraumatic%2Bbrain%2Binjury%3A%2Ba%2Bpilot%2Bstudy.%2BJ%2BTrauma%3B%2B2009%3B%2B67%3A%2B277-282.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Pascual%2BJL%2C%2BMaloney-Wilensky%2BE%2C%2BReilly%2BPM%2C%2BSicoutris%2BC%2C%2BKeutmann%2BMK%2C%2BStein%2BSC%2C%2BLeRoux%2BPD%2C%2BGracias%2C%2BVH%3A%2BResuscitation%2Bof%2Bhypotensive%2Bhead-injured%2Bpatients%3A%2Bis%2Bhypertonic%2Bsaline%2Bthe%2Banswer%3F%2BAm%2BSurg%3B%2B2008%3B%2B74(3)%3A%2B253-259.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Hartl%2BR%2C%2BGhajar%2BJ%2C%2BHochleuthner%2BH%2C%2B%2BMauritz%2BW%3A%2BHypertonic%2Fhyperoncotic%2Bsaline%2Breliably%2Breduces%2BICP%2Bin%2Bseverely%2Bhead-injured%2Bpatients%2Bwith%2Bintracranial%2Bhypertension.%2BActa%2BNeurochir%2BSuppl%3B%2B1997%3B%2B70%3A%2B126-129.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Hartl%2BR%2C%2BGhajar%2BJ%2C%2BHochleuthner%2BH%2C%2BMauritz%2BW%3A%2BTreatment%2Bof%2Brefractory%2Bintracranial%2Bhypertension%2Bin%2Bsevere%2Btraumatic%2Bbrain%2Binjury%2Bwith%2Brepetitive%2Bhypertonic%2Fhyperoncotic%2Binfusions.%2BZentralbl%2BChir%3B%2B1997%3B%2B122(3)%3A%2B181-185.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Harutjunyan%2BL%2C%2BHolz%2BC%2C%2BRieger%2BA%2C%2BMenzel%2BM%2C%2BGrond%2BS%2C%2BSoukup%2BJ%3A%2BEfficiency%2Bof%2B7.2%25%2Bhypertonic%2Bsaline%2Bhydroxyethyl%2Bstarch%2B200%2F0.5%2Bversus%2Bmannitol%2B15%25%2Bin%2Bthe%2Btreatment%2Bof%2Bincreased%2Bintracranial%2Bpressure%2Bin%2Bneurosurgical%2Bpatients%2B-%2Ba%2Brandomized%2Bclinical%2Btrial.%2BCrit%2BCare%3B%2B2005%3B%2B9(5)%3A%2BR530-40.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Qureshi%2BAI%2C%2BSuarez%2BJI%2C%2BBhardwaj%2BA%3A%2BMalignant%2Bcerebral%2Bedema%2Bin%2Bpatients%2Bwith%2Bhypertensive%2Bintracerebral%2Bhemorrhage%2Bassociated%2Bwith%2Bhypertonic%2Bsaline%2Binfusion%3A%2BA%2Brebound%2Bphenomenon%3F%2BJournal%2Bof%2BNeurosurg%2BAnesthesiol%3B%2B1998%3B%2B10(3)%3A%2B188-192.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Qureshi%2BAI%2C%2BSuarez%2BJI%2C%2BBhardwaj%2BA%2C%2BMirski%2BM%2C%2BSchnitzer%2BMS%2C%2BHanley%2BDF%2C%2BUlatowski%2C%2BJ%3A%2BUse%2Bof%2Bhypertonic%2B(3%25)%2Bsaline%2Facetate%2Binfusion%2Bin%2Bthe%2Btreatment%2Bof%2Bcerebral%2Bedema%3A%2BEffect%2Bon%2Bintracranial%2Bpressure%2Band%2Blateral%2Bdisplacement%2Bof%2Bthe%2Bbrain.%2BCrit%2BCare%2BMed%3B%2B1998%3B%2B26(3)%3A%2B440-446.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Rockswold%2BG%2C%2BSolid%2BC%2C%2BParedes-Andrade%2BE%2C%2BRockswold%2BS%2C%2BJancik%2BJ%2C%2BQuickel%2BR%3A%2B%2BHypertonic%2Bsaline%2Band%2Bits%2Beffect%2Bon%2Bintracranial%2Bpressure%2C%2Bcerebral%2Bperfusion%2Bpressure%2Band%2Bbrain%2Btissue%2Boxygenation.%2BNeurosurgery%3B%2B2009%3B%2B65%3A%2B1035-1042.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Kerwin%2BA%2C%2BSchinco%2BM%2C%2BTepas%2BJ%2C%2BRenfro%2BW%2C%2BVitarbo%2BE%2C%2BMuehlberger%2BM%3A%2BThe%2Buse%2Bof%2B23.4%25%2Bhypertonic%2Bslaine%2Bfor%2Bthe%2Bmanagement%2Bof%2Belevated%2Bintracranial%2Bpressure%2Bin%2Bpatients%2Bwith%2Bsevere%2Btraumatic%2Bbrain%2Binjury%3A%2Ba%2Bpilot%2Bstudy.%2BJ%2BTrauma%3B%2B2009%3B%2B67%3A%2B277-282.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Pascual%2BJL%2C%2BMaloney-Wilensky%2BE%2C%2BReilly%2BPM%2C%2BSicoutris%2BC%2C%2BKeutmann%2BMK%2C%2BStein%2BSC%2C%2BLeRoux%2BPD%2C%2BGracias%2C%2BVH%3A%2BResuscitation%2Bof%2Bhypotensive%2Bhead-injured%2Bpatients%3A%2Bis%2Bhypertonic%2Bsaline%2Bthe%2Banswer%3F%2BAm%2BSurg%3B%2B2008%3B%2B74(3)%3A%2B253-259.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Hartl%2BR%2C%2BGhajar%2BJ%2C%2BHochleuthner%2BH%2C%2B%2BMauritz%2BW%3A%2BHypertonic%2Fhyperoncotic%2Bsaline%2Breliably%2Breduces%2BICP%2Bin%2Bseverely%2Bhead-injured%2Bpatients%2Bwith%2Bintracranial%2Bhypertension.%2BActa%2BNeurochir%2BSuppl%3B%2B1997%3B%2B70%3A%2B126-129.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Hartl%2BR%2C%2BGhajar%2BJ%2C%2BHochleuthner%2BH%2C%2BMauritz%2BW%3A%2BTreatment%2Bof%2Brefractory%2Bintracranial%2Bhypertension%2Bin%2Bsevere%2Btraumatic%2Bbrain%2Binjury%2Bwith%2Brepetitive%2Bhypertonic%2Fhyperoncotic%2Binfusions.%2BZentralbl%2BChir%3B%2B1997%3B%2B122(3)%3A%2B181-185.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Harutjunyan%2BL%2C%2BHolz%2BC%2C%2BRieger%2BA%2C%2BMenzel%2BM%2C%2BGrond%2BS%2C%2BSoukup%2BJ%3A%2BEfficiency%2Bof%2B7.2%25%2Bhypertonic%2Bsaline%2Bhydroxyethyl%2Bstarch%2B200%2F0.5%2Bversus%2Bmannitol%2B15%25%2Bin%2Bthe%2Btreatment%2Bof%2Bincreased%2Bintracranial%2Bpressure%2Bin%2Bneurosurgical%2Bpatients%2B-%2Ba%2Brandomized%2Bclinical%2Btrial.%2BCrit%2BCare%3B%2B2005%3B%2B9(5)%3A%2BR530-40.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Qureshi%2BAI%2C%2BSuarez%2BJI%2C%2BBhardwaj%2BA%3A%2BMalignant%2Bcerebral%2Bedema%2Bin%2Bpatients%2Bwith%2Bhypertensive%2Bintracerebral%2Bhemorrhage%2Bassociated%2Bwith%2Bhypertonic%2Bsaline%2Binfusion%3A%2BA%2Brebound%2Bphenomenon%3F%2BJournal%2Bof%2BNeurosurg%2BAnesthesiol%3B%2B1998%3B%2B10(3)%3A%2B188-192.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Qureshi%2BAI%2C%2BSuarez%2BJI%2C%2BBhardwaj%2BA%2C%2BMirski%2BM%2C%2BSchnitzer%2BMS%2C%2BHanley%2BDF%2C%2BUlatowski%2C%2BJ%3A%2BUse%2Bof%2Bhypertonic%2B(3%25)%2Bsaline%2Facetate%2Binfusion%2Bin%2Bthe%2Btreatment%2Bof%2Bcerebral%2Bedema%3A%2BEffect%2Bon%2Bintracranial%2Bpressure%2Band%2Blateral%2Bdisplacement%2Bof%2Bthe%2Bbrain.%2BCrit%2BCare%2BMed%3B%2B1998%3B%2B26(3)%3A%2B440-446.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Rockswold%2BG%2C%2BSolid%2BC%2C%2BParedes-Andrade%2BE%2C%2BRockswold%2BS%2C%2BJancik%2BJ%2C%2BQuickel%2BR%3A%2B%2BHypertonic%2Bsaline%2Band%2Bits%2Beffect%2Bon%2Bintracranial%2Bpressure%2C%2Bcerebral%2Bperfusion%2Bpressure%2Band%2Bbrain%2Btissue%2Boxygenation.%2BNeurosurgery%3B%2B2009%3B%2B65%3A%2B1035-1042.%0A&hl=en&lr=&btnG=Search -
8/6/2019 Hyper Tonic Saline in the Treatment of Intracranial Hypertension
19/19
39. Schatzmann C, Heissler HE, Konig K, Klinge-Xhemajli P, Rickels E, Muhling M,
Borschel M, Samil, M: Treatment of elevated intracranial pressure by infusions of 10%
saline in severely head injured patients. Acta Neurochir Suppl; 1998; 71: 31-33. (s)
40. Ware ML, Nemani VM, Meeker M, Lee C, Morabito D J, Manley GT: Effects of
23.4% sodium chloride solution in reducing intracranial pressure in patients with
traumatic brain injury: a preliminary study. Neurosurgery; 2005; 57(4): 727-736. (s)
41. Worthley LI, Cooper DJ, Jones N: Treatment of resistant intracranial hypertension
with hypertonic saline. J Neurosurg; 1988; 68(3): 478-481. (s)
http://scholar.google.ca/scholar?q=Schatzmann%2BC%2C%2BHeissler%2BHE%2C%2BKonig%2BK%2C%2BKlinge-Xhemajli%2BP%2C%2BRickels%2BE%2C%2BMuhling%2BM%2C%2BBorschel%2BM%2C%2BSamil%2C%2BM%3A%2BTreatment%2Bof%2Belevated%2Bintracranial%2Bpressure%2Bby%2Binfusions%2Bof%2B10%25%2Bsaline%2Bin%2Bseverely%2Bhead%2Binjured%2Bpatients.%2BActa%2BNeurochir%2BSuppl%3B%2B1998%3B%2B71%3A%2B31-33.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Ware%2BML%2C%2BNemani%2BVM%2C%2BMeeker%2BM%2C%2BLee%2BC%2C%2BMorabito%2BD%2BJ%2C%2BManley%2BGT%3A%2BEffects%2Bof%2B23.4%25%2Bsodium%2Bchloride%2Bsolution%2Bin%2Breducing%2Bintracranial%2Bpressure%2Bin%2Bpatients%2Bwith%2Btraumatic%2Bbrain%2Binjury%3A%2Ba%2Bpreliminary%2Bstudy.%2BNeurosurgery%3B%2B2005%3B%2B57(4)%3A%2B727-736.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Worthley%2BLI%2C%2BCooper%2BDJ%2C%2BJones%2BN%3A%2BTreatment%2Bof%2Bresistant%2Bintracranial%2Bhypertension%2Bwith%2Bhypertonic%2Bsaline.%2BJ%2BNeurosurg%3B%2B1988%3B%2B68(3)%3A%2B478-481.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Schatzmann%2BC%2C%2BHeissler%2BHE%2C%2BKonig%2BK%2C%2BKlinge-Xhemajli%2BP%2C%2BRickels%2BE%2C%2BMuhling%2BM%2C%2BBorschel%2BM%2C%2BSamil%2C%2BM%3A%2BTreatment%2Bof%2Belevated%2Bintracranial%2Bpressure%2Bby%2Binfusions%2Bof%2B10%25%2Bsaline%2Bin%2Bseverely%2Bhead%2Binjured%2Bpatients.%2BActa%2BNeurochir%2BSuppl%3B%2B1998%3B%2B71%3A%2B31-33.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Ware%2BML%2C%2BNemani%2BVM%2C%2BMeeker%2BM%2C%2BLee%2BC%2C%2BMorabito%2BD%2BJ%2C%2BManley%2BGT%3A%2BEffects%2Bof%2B23.4%25%2Bsodium%2Bchloride%2Bsolution%2Bin%2Breducing%2Bintracranial%2Bpressure%2Bin%2Bpatients%2Bwith%2Btraumatic%2Bbrain%2Binjury%3A%2Ba%2Bpreliminary%2Bstudy.%2BNeurosurgery%3B%2B2005%3B%2B57(4)%3A%2B727-736.%0A&hl=en&lr=&btnG=Searchhttp://scholar.google.ca/scholar?q=Worthley%2BLI%2C%2BCooper%2BDJ%2C%2BJones%2BN%3A%2BTreatment%2Bof%2Bresistant%2Bintracranial%2Bhypertension%2Bwith%2Bhypertonic%2Bsaline.%2BJ%2BNeurosurg%3B%2B1988%3B%2B68(3)%3A%2B478-481.%0A&hl=en&lr=&btnG=Search